IES Engineers | Service: BioSafety


Centocor
IES prepared a tailored Cytometer Safety Plan to provide guidance for new and existing employees who use Cytometers on-site or frequent Cytometer use areas to ensure they understood Centocor Cytometer policies, procedures and expectations.
more>


Adolor

American Inks & Coatings

Andrx

Aventis

Cardinal Health

Centocor

Congoleum

Crozer-Chester Medical Center

Elan Pharmaceuticals

Elementis Specialties

Emisphere

EON Laboratories

Fisher Clinical

Gentara Corporation

GlaxoSmithKline

Johnson & Johnson

Kraft

Lonza

Markel Corporation

Morphotek, Inc.

Novopharm

Nucleonics

OHM Laboratories

Pfizer

Purdue Pharmaceuticals

Rhodia

Sharp Corporation

TEVA

Watson Labs


expanded list>

BioSafety

IES provides Biosafety services to a variety of industries, including pharmaceutical, biotech and hospitals. The IES staff includes Certified Industrial Hygienists, Registered Biosafety Professionals, and Certified Safety Professionals.

IES Biosafety services are tailored to each client based on the type of work performed, client goals, specific issues, existing corporate policies, and IES experience.

IES Biosafety services include, but are not limited to:
- Bloodborne Pathogen Program Development (29 CFR 1910.1030)
- Exposure Control Plan Development
- Customized Biosafety Training
- BSL-3 Design, Certification, Training and SOP Development
- Waste Program Development
- Auditing
- Annual Review and Revision of the Exposure Control Plan
- Decommissioning
- Cytometer Safety

Advantages of using IES for your Biosafety needs include:
- IES’ regulatory and site experience
- Guaranteed Regulatory Compliance
- Tailored user friendly documents
- Customized Training


Team Leader


GEORGE S. PETROKA, CIH, CSP, RBP

 


Sharps Injury Logs
Are you maintaining a separate Sharps Injury Log in addition to your OSHA 300 Injury and Illness Log?
more>

Decommissioning/Decontamination…Beyond the ASTM Phase I Process
IES can help the client meet regulatory requirements required in the selling or transferring of property, where radiological, chemical or biological materials were in use or production.
more>


Guidelines & Standards

NIH Scientific Resources

BMBL 4th Edition

Organizations

ABSA

Regulations

29 CFR 1910.1030

CDC Select Agent Program